EPC · EDGEWELL PERSONAL CARE Co
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q3 FY26 earnings call · Aug 5, 2026TL;DR. Edgewell reported Q3 organic net sales growth of 1.1% with adjusted EPS and adjusted EBITDA exceeding expectations, but lowered full-year organic sales and adjusted gross margin guidance. Management maintained full-year adjusted EPS and adjusted EBITDA midpoints and stronger Q4 performance expectations.
- + Q3 adjusted EPS and adjusted EBITDA exceeded expectations
- + Full-year adjusted EPS midpoint held at prior range of $1.80 to $2.00 and adjusted EBITDA midpoint at $250 to $260 million
- + Management expects material Q4 gross margin expansion driven by productivity, cycling of one-time items, and favorable FX
- − International organic sales declined 1.4% in Q3 due to temporary supply chain and Middle East disruption
- − Full-year adjusted gross margin outlook lowered to +~20 bps from prior +~50 bps
- − Q3 adjusted gross margin declined 30 bps to 44.5% as core inflation and tariffs more than offset productivity
- − Full-year adjusted operating margin outlook worsened to -~80 bps from prior -~60 bps
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EPC
this stock
EDGEWELL PERSONAL CARE Co
|
$1.28B | +58.2% | -1.3% | — | 9.9% |
|
PG
PROCTER & GAMBLE Co
|
$339.90B | +1.4% | +3.3% | 22.1 | 1.0% |
|
UL
Unilever PLC
|
$134.67B | -7.1% | — | — | 0.2% |
|
CL
Colgate Palmolive Co
|
$69.13B | +8.0% | +1.7% | 34.3 | 2.3% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$41.79B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EPC | -0.4% | -3.4% | +20.8% | -6.1% | +58.2% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +0.3% | -3.6% | +8.6% | -5.5% | +46.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.